Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Kevin R. Rogacki MD

Kevin R. Rogacki MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology

Member of the Cancer Center


Publications (8)

  • Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiation Therapy for Head and Neck Cancer. (Rogacki KR, Teo PT, Gopalakrishnan M, Pachigolla SL, Lyons CE, Abazeed ME, Das I, Mittal BB, Gentile M) Adv Radiat Oncol 2024 Sep;9(9):101545 PMID: 39184143 PMCID: PMC11343725 SCOPUS ID: 2-s2.0-85200164174 08/26/2024       9 Citations
  • Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature selection (Teo PT, Rogacki K, Gopalakrishnan M, Das IJ, Abazeed ME, Mittal BB, Gentile M) Clinical and Translational Radiation Oncology May 2024;46 SCOPUS ID: 2-s2.0-85186517568 05/01/2024       18 Citations
  • Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma. (Gopal P, Petty A, Rogacki K, Bera T, Bareja R, Peacock CD, Abazeed ME) Sci Adv 2022 Dec 14;8(50):eabp8674 PMID: 36516249 PMCID: PMC9750150 SCOPUS ID: 2-s2.0-85144198406 12/15/2022       17 Citations
  • Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapy (Manyam BV, Verdecchia K, Rogacki K, Reddy CA, Zhuang T, Videtic GMM, Azok J, Stephans K) Journal of Radiosurgery and Sbrt 2019;6(3):189-197 SCOPUS ID: 2-s2.0-85071452242 01/01/2019       9 Citations
  • Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review. (Murphy ES, Rogacki K, Godley A, Qi P, Reddy CA, Ahluwalia MS, Peereboom DM, Stevens GH, Yu JS, Kotecha R, Suh JH, Chao ST) Pract Radiat Oncol 2017;7(6):e391-e399 PMID: 28666902 SCOPUS ID: 2-s2.0-85021780843 07/02/2017       16 Citations
  • Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy. (Li Z, Alyamani M, Li J, Rogacki K, Abazeed M, Upadhyay SK, Balk SP, Taplin ME, Auchus RJ, Sharifi N) Nature 2016 May 26;533(7604):547-51 PMID: 27225130 PMCID: PMC5111629 SCOPUS ID: 2-s2.0-84971273444 05/27/2016       157 Citations
  • A genetic basis for the variation in the vulnerability of cancer to DNA damage. (Yard BD, Adams DJ, Chie EK, Tamayo P, Battaglia JS, Gopal P, Rogacki K, Pearson BE, Phillips J, Raymond DP, Pennell NA, Almeida F, Cheah JH, Clemons PA, Shamji A, Peacock CD, Schreiber SL, Hammerman PS, Abazeed ME) Nat Commun 2016 Apr 25;7:11428 PMID: 27109210 PMCID: PMC4848553 SCOPUS ID: 2-s2.0-84964659853 04/26/2016       146 Citations
  • Integrative analysis of the zinc finger transcription factor Lame duck in the Drosophila myogenic gene regulatory network. (Busser BW, Huang D, Rogacki KR, Lane EA, Shokri L, Ni T, Gamble CE, Gisselbrecht SS, Zhu J, Bulyk ML, Ovcharenko I, Michelson AM) Proc Natl Acad Sci U S A 2012 Dec 11;109(50):20768-73 PMID: 23184988 PMCID: PMC3528522 SCOPUS ID: 2-s2.0-84874416769 11/28/2012       20 Citations
  • Last update: 06/24/2026